SCHEMBL25016428

SCHEMBL25016428

c1ccc(-c2nc(-c3cccc4c3sc3ccccc34)nc(-c3cccc4sc5cccc(-c6nc(-c7ccccc7)c7sc8ccccc8c7n6)c5c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.40
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ ATM Q13315 1/20 0.37
▸ LIMK1 P53667 3/20 0.36
▸ TNKS O95271 3/20 0.34
▸ TNKS2 Q9H2K2 3/20 0.34
▸ PARP14 Q460N5 1/20 0.33
▸ PRKDC P78527 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ PIK3CD O00329 1/20 0.31
▸ PIK3CB P42338 1/20 0.31
▸ HRH4 Q9H3N8 1/20 0.31
▸ GPR3 P46089 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ MMP14 P50281 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25017055 0.97 ALOX5 (0.38) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL22195675 0.97 ALOX5 (0.38) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL25017319 0.95 MEN1 (0.40) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL22195581 0.94 MEN1 (0.38) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL22329998 0.94 MEN1 (0.38) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL22195475 0.94 LIMK1 (0.36) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL25017766 0.94 LIMK1 (0.36) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL25017451 0.94 ALOX5 (0.41) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL22330286 0.94 MEN1 (0.38) ALOX5MEN1KMT2AATMLIMK1
SCHEMBL25016419 0.94 MEN1 (0.39) ALOX5MEN1KMT2AATMLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2023-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same CYBA, SUN2, TMEM109 ALOX5 366/4885MEN1 1118/4885KMT2A 3445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback